SMTL ID : 7vs0.1

crystal structure of BRD2-BD2 in complex with purine derivative

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.25 Å

Oligo State

monomer

Ligands

2 x 7UH: Doxofylline(Non-covalent)

7UH.1: 9 residues within 4Å: Chain A: W.30, P.31, F.32, V.36, L.41, L.43, Y.88, N.89, V.95 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.89 7UH.2: 2 residues within 4Å: Chain A: W.30, Y.33 4 PLIP interactions: 4 interactions with chain A Water bridges: A:Y.33 pi-Stacking: A:W.30, A:W.30, A:W.30

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.3: 3 residues within 4Å: Chain A: K.62, D.67, E.73 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.62, A:K.62

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Arole, A.H. et al., Structural and biochemical insights into purine-based drug molecules in hBRD2 delineate a unique binding mode opening new vistas in the design of inhibitors of the BET family. Acta Crystallogr D Struct Biol (2023)

Release Date

2023-02-01

Peptides

Bromodomain-containing protein 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bromodomain-containing protein 2

Related Entries With Identical Sequence